Scrip | What Does 2022 Hold For Biopharma?
Feb 2022
Originally published by SCRIP on February 8 , 2022.
James West, Director in Lincoln’s Healthcare Group shares that there has been increased private equity firm’s interest in the Biopharma space and expects continued activity in this sphere for the year 2022 .
Summary
-
James West, Director at Lincoln International's Healthcare Group speaks with Scrip on Biopharma market and trends for 2022.
- Sign up to receive Lincoln's perspectives
Share: 
